Lista de obras - Raffaele Ratta - Dominio Público Uruguay

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

artículo científico publicado en 2016

Castration-naive metastatic prostate cancer: reshaping old paradigms

artículo científico publicado en 2017

Combination therapies for patients with metastatic renal cell carcinoma.

artículo científico publicado en 2018

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

artículo científico

Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?

artículo científico publicado en 2017

Evolving treatment landscape in metastatic renal cell carcinoma: where are we now?

artículo científico publicado en 2016

Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world Analysis.

artículo científico publicado en 2018

Immunotherapy advances in uro-genital malignancies

artículo científico publicado en 2016

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

artículo científico publicado en 2015

Improved quality of life is the way to longer life

artículo científico publicado en 2016

Multimodal treatment of advanced renal cancer in 2017.

artículo científico publicado en 2017

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

artículo científico publicado en 2016

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis

artículo científico publicado en 2017

PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review

artículo científico publicado en 2020

Pazopanib and pancreatic toxicity: a case report.

artículo científico publicado en 2015

Predicting Molecular Models: Where Are We Going?

artículo científico

Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme

artículo científico publicado en 2015

Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme

article

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

artículo científico publicado en 2016

What advances have been made in immune-therapy for renal cell carcinoma?

artículo científico publicado en 2017

Lista de obras de Raffaele Ratta

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

Castration-naive metastatic prostate cancer: reshaping old paradigms

Combination therapies for patients with metastatic renal cell carcinoma.

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?

Evolving treatment landscape in metastatic renal cell carcinoma: where are we now?

Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world Analysis.

Immunotherapy advances in uro-genital malignancies

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

Improved quality of life is the way to longer life

Multimodal treatment of advanced renal cancer in 2017.

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis

PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review

Pazopanib and pancreatic toxicity: a case report.

Predicting Molecular Models: Where Are We Going?

Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme

Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

What advances have been made in immune-therapy for renal cell carcinoma?